Underscoring this point, we previously showed that CAR-iNKT cells are more effective against CD1d-expressing lymphoma than their CAR T-cell counterparts,26,30 and KMT2Ar ProB ALL has been previously reported to express CD1d. Here, CD1D is linked to acute lymphoblastic leukemia.